​

SAB Biotherapeutics Ownership | Who Owns SAB Biotherapeutics?

OverviewForecastRevenueFinancialsChart

SAB Biotherapeutics Ownership Summary

SAB Biotherapeutics is owned by 5.11% institutional investors, and 94.89% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.52% of its assets in SAB Biotherapeutics shares.

SABS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockSAB Biotherapeutics5.11%-94.89%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2023375.71%26,785,910591.27%58.65%1550.00%350.00%
Sep 30, 202335-7.89%3,874,859-2.09%712.46%10-16.67%2-50.00%
Jun 30, 2023382.70%3,957,7032.29%713.32%129.09%4-42.86%
Mar 31, 2023372.78%3,868,963-5.44%78.69%11-35.29%7-12.50%
Dec 31, 2022362.86%4,091,45923.76%915.92%1721.43%833.33%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv232.57K2.52%-
Vanguard Institutional Extnd Mkt Idx Tr43.81K0.47%85.00
Fidelity Extended Market Index40.85K0.44%-260.00
iShares Micro-Cap ETF14.61K0.16%-
Fidelity Total Market Index12.90K0.14%-
Fidelity Series Total Market Index9.83K0.11%-
NT Ext Equity Mkt Idx Fd - L8.64K0.09%-
Northern Trust Extended Eq Market Idx8.64K0.09%6.72K
Spartan Extended Market Index Pool E8.00K0.09%260.00
Spartan Extended Market Index Pool F8.00K0.09%260.00

Insider Transactions Trends

DateBuySell
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q43-
2023 Q2--

SABS Ownership FAQ

Who Owns SAB Biotherapeutics?

SAB Biotherapeutics shareholders are primarily institutional investors at 5.11%, followed by 0% insiders and 0% retail investors. The average institutional ownership in SAB Biotherapeutics's industry, Biotech Stocks , is 68.48%, which SAB Biotherapeutics falls below.

Does Blackrock own SAB Biotherapeutics?

BlackRock is not among the top 10 institutional shareholders of SAB Biotherapeutics.

Who is the top mutual fund holder of SAB Biotherapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of SAB Biotherapeutics shares, with 2.52% of its total shares outstanding invested in 232.57K SAB Biotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools